Physician profile
Michael S Ising
NPI 1427442540
$4,907.60
in general payments reported to CMS, 2019-2025
14 companies · $2,130 in 2025
The $2,130 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $508 · 2023: $1,124 · 2024: $868 · 2025: $2,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,651 · Travel and Lodging: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,650.91 |
| Travel and Lodging | $471.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,077.35 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $1,025.24 | 2023-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $769.10 | 2025 | |
| Medtronic, INC. | $714.94 | 2022-2023 | Corevalve Evolut R |
| Abbott Laboratories | $546.49 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Epic |
| Boston Scientific Corporation | $256.37 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $139.97 | 2025 | |
| Corcym INC | $118.03 | 2025 | Perceval |
| Solventum Corporation | $110.42 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C. Granufoam |
| Arthrex, INC. | $58.08 | 2025 | |
| Kls-Martin L.P. | $33.21 | 2024 | |
| Artivion, INC. | $23.45 | 2025 | Amds-Ascyrus Medical |
| Pfizer INC. | $21.06 | 2021 | |
| Kci USA, INC. | $13.89 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ising listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.